Metropolis Healthcare Ltd

Blood sugar result of less than 70mg/dL is usually considered low blood sugar, commonly known as hypoglycemia. It primarily affects people with diabetes, especially those who take insulin. Low blood sugar, much to everyone’s surprise, can also occur in non-diabetic patients. In an interview with Onlymyhealth editorial team, Dr Shefali Desai, AVP, Desai Metropolis Healthcare (Surat) discusses the causes and symptoms of low blood sugar and the different ways to manage it. #Bloodsugar #Bloodsugarcontrol #Diabetes #Hypoglycemia #Insulin #PreventativeHealth #Wellness #Truhealth #MetropolisLab #Healthcare #MetropolisScientificExperthttps://www.onlymyhealth.com/causes-of-low-blood-sugar-in-people-with-no-diabetes-1682935623 #Bloodsugar #Bloodsugarcontrol #Diabetes #Hypoglycemia #Insulin #PreventativeHealth #Wellness #Truhealth #MetropolisLab #Healthcare #MetropolisScientificExpert

At Metropolis Labs, we are committed to bringing new testing technologies that will assist doctors in making better clinical decisions and treatments, thereby enhancing the quality of patient care. In this direction, we are pleased to announce the #NextGenHLA Typing Test, which is powered by the complex molecular technology #nextgenerationsequencing (NGS). Metropolis' NextGen HLA Typing is a molecular test, which is performed for Bone Marrow Transplantation, also known as Hematopoietic Stem Cell Transplant (HSCT) & in Solid organ transplants such as Kidney transplants. This test aids in the identification of a suitable donor for bone marrow, cord blood, or organ transplant by analysing the Human Leukocyte Antigen (HLA) genes that a person has inherited from the parents. We believe that this test will help doctors find the right donors for their patients, resulting in successful transplants and higher survival rates. Metropolis Healthcare has established a centre of excellence for all transplant-related diagnostic services over the years, including the most comprehensive array of diagnostic tools, reports with more accurate interpretation, expert laboratory professionals, and subject matter specialists, making Metropolis a one-stop solution for all the transplant-related diagnostic needs. #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomicshttps://indiamedtoday.com/metropolis-launches-nextgen-hla-test-for-hsct-solid-organ-transplantation/ #NextGenHLA #nextgenerationsequencing #MetropolisLab #Healthcare #DiagnosticLeader #Innovation #MetropolisScientificExpert #MolecularGenomics

Check out this article in @ETHealth World authored by our #MetropolisScientificExpert Dr. Niranjan Patil, who explains how Whole Genome Sequencing by NGS Technology can aid in the diagnosis and management of drug-resistant tuberculosis. Dr. Niranjan Patil is the HOD and Scientific Business Head, Clinical Microbiology and Molecular Biology at Metropolis Healthcare's Global Reference Laboratory in Mumbai. #MetropolisHealthcare #LeadersinDiagnostics #Virology #innovationen #ScientificExpertise #MolecularGenomics #NextGenerationSequencinghttps://health.economictimes.indiatimes.com/news/diagnostics/current-role-of-application-of-whole-genome-sequencing-by-ngs-technology-in-drug-resistant-tb-diagnosis-and-management/98965752#:~:text=Whole%20genome%20sequencing%20by%20NGS%20has%20tremendous%20potential%20for%20quickly,the%20WGS%20by%20NGS%20methodology #MetropolisScientificExpert #MetropolisHealthcare #LeadersinDiagnostics #Virology #innovationen #ScientificExpertise #MolecularGenomics #NextGenerationSequencing

"The complexities of clinical presentations and the wide range of diagnostic tests available highlight the role of artificial intelligence (AI) and machine learning (ML) tools in supporting the National Tuberculosis Elimination Programme. It is critical to choose the right test/s for the prevailing clinical situation and to interpret the test results correctly," says Dr. Rohini Kelkar to ETHealthWorld. Check out this in-depth & insightful piece in which Dr. Rohini joins other scientific experts to share how digital technologies have been critical in enabling prompt and accurate tuberculosis diagnosis. #MetropolisScientificExpert Dr. Rohini Kelkar is the Senior Consultant, Infectious Diseases, Clinical Microbiology and Molecular Microbiology at Metropolis Healthcare Limited. At Metropolis, we all understand that underdiagnosis and multi-drug resistance are two aspects of Tuberculosis that require timely, accurate, and accessible diagnostic support. For more than a decade, Metropolis has provided the most comprehensive range of Tuberculosis tests, all of which are approved and recommended by WHO. The company has a dedicated Infectious Disease Division #Microxpert that has been assisting patients and clinicians from diagnosis to treatment by providing access to accurate lab results and WHO/NTEP approved advisory services via a novel model developed by Metropolis Healthcare's Innovation Cell. Metropolis has collaborated and worked with Central and State Government departments, Public Health departments, and Municipal Corporations across the country. Metropolis believes that its efforts in a variety of ways will help to strengthen the government's efforts to meet the TB elimination goals by 2025. Through CME Programs, national and international conferences, and information sharing, the company has been working to raise awareness among the medical community and laboratory practitioners about the latest trends and advancements in TB diagnosis. Furthermore, under the "Pradhan Mantri TB Mukt Abhiyan" initiative, the company has adopted 650 TB patients in Mumbai and has been providing nutritional support to them. #MetropolisHealthcare #LeadersinDiagnostics #Virology #Innovation #ScientificExpertise #CaringforCommunities #CorporateSocialresponsibility #TBEliminationProgramme #CSR #ESG #Sustainability #CreatingImpact #MetropolisbeyondDiagnostics #MolecularGenomics #NextGenerationSequencing https://health.economictimes.indiatimes.com/news/diagnostics/eliminate-tb-by-2025-indias-pipe-dream/98976231 #MetropolisScientificExpert #Microxpert #MetropolisHealthcare #LeadersinDiagnostics #Virology #Innovation #ScientificExpertise #CaringforCommunities #CorporateSocialresponsibility #TBEliminationProgramme #CSR #ESG #Sustainability #CreatingImpact #MetropolisbeyondDiagnostics #MolecularGenomics #NextGenerationSequencing

According to an Indian Council of Medical Research (ICMR) study, one in nine Indians are likely to develop cancer in their lifetime. It is not women who are being affected with cancer, men are also equally at risk with the cancer prevalence continually showing an upward trend among them. Here’s an article authored by Dr Shaikhali Barodawala, Scientific and Business Head, Integrated Oncopathology, Consultant and Head, Anatomic Pathology, Global Reference Laboratory, Metropolis Labs, in which he briefly highlights on the most common cancer symptoms for men in order to seek timely care and detection. #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeaderhttps://health.economictimes.indiatimes.com/news/industry/minimizing-the-fear-of-unknown-mens-common-cancer-symptoms/98036165 #MetropolisLabs #MetropolisScientificExpert #Healthcare #Oncomet #SuperSpeciality #CancerDiagnosis #Oncology #DiagnosticLeader

#DiagnosticOncology has come a long way courtesy of technological advancement, precision oncology, and companion diagnostics culminating into optimal patient care. This #worldcancerday2023 , Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs joins other leading Oncology specialists to share her views with The Times of India on the advancements in diagnosis and treatment of cancer. #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab #DiagnosticOncology #worldcancerday2023 #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab

The Covid-19 pandemic in India and its different waves have led to several complications in recovered patients. The latest complication observed is “Avascular Necrosis”. In this #Lallantop episode of Sehat, Dr Shaikhali Barodawala (Scientific and Business Head – Integrated Oncopathology, Consultant and Head – Anatomic Pathology, Global Reference Laboratory, Metropolis Healthcare Ltd) explains about Avascular Necrosis's relation to Covid-19 and treatment. Do watch to know more. #MetropolisLabs #Healthcare #Covid19 The Lallantop #MetropolisScientificExperthttps://www.youtube.com/watch?v=JxX3WO4bWpU #Lallantop #MetropolisLabs #Healthcare #Covid19 #MetropolisScientificExpert

Metropolis’ Group Company #HITECHDiagnosticCentre bags the ‘Silver Award’ for Excellence in Pathology Services at the 8th India Health and Wellness Awards by IHW Council. Established in the year 1986, Hitech Diagnostic Centre is a well-known diagnostics laboratory chain in the Tamil Nadu with a network of 17 laboratories and 68 collection centres strategically spread across the states of Tamil Nadu and Union Territory of Pondicherry. It is the 2nd largest player in Chennai and is a leader in non-Chennai markets in the state of Tamil Nadu. Hitech has been catering to the mid-segment of the market and has a larger B2C footprint. It has a test menu of 1,100+ tests ranging from routine to highly impenetrable molecular and genetic essays. Metropolis Healthcare’s Dr. Nilesh Shah, President and Chief of Research and Innovation and Dr. Kirti Chadha, Chief Scientific Officer and Group Head – CSR received the award at the event held in Mumbai. #MetropolisHealthcare #MetropolisLabs #HitechDiagnostics #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #PathologyServices #HITECHDiagnosticCentre #MetropolisHealthcare #MetropolisLabs #HitechDiagnostics #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #PathologyServices

Metropolis’ Group Company bags the ‘Silver Award’ for Excellence in Pathology Services at the 8th India Health and Wellness Awards by IHW Council. Established in the year 1986, Hitech Diagnostic Centre is a well-known diagnostics laboratory chain in the Tamil Nadu with a network of 17 laboratories and 68 collection centres strategically spread across the states of Tamil Nadu and Union Territory of Pondicherry. It is the 2nd largest player in Chennai and is a leader in non-Chennai markets in the state of Tamil Nadu. Hitech has been catering to the mid-segment of the market and has a larger B2C footprint. It has a test menu of 1,100+ tests ranging from routine to highly impenetrable molecular and genetic essays. Metropolis Healthcare’s Dr. Nilesh Shah, President and Chief of Research and Innovation and Dr. Kirti Chadha, Chief Scientific Officer and Group Head – CSR received the award at the event held in Mumbai. #HITECHDiagnosticCentre #MetropolisHealthcare #MetropolisLabs #HitechDiagnostics #IHWCouncil #HealthandWellness #Recognition #MetropolisScientificexpert #DiagnosticsLeader #Science #Excellence #Innovation #PathologyServices